Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray for preoperative anxiety in breast cancer surgery
ChiCTR2400089060Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Fujian Medical University
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dexmedetomidine in preoperative anxiety and breast cancer (4 arms), sponsored by The Second Affiliated Hospital of Fujian Medical University. Primary endpoints: Preoperative and postoperative anxiety scores, Postoperative sleep scores and 1 more. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
preoperative anxietybreast cancer
Beyond the preview
Go deeper on ChiCTR2400089060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089060.